JP2023554674A5 - - Google Patents
Info
- Publication number
- JP2023554674A5 JP2023554674A5 JP2023537498A JP2023537498A JP2023554674A5 JP 2023554674 A5 JP2023554674 A5 JP 2023554674A5 JP 2023537498 A JP2023537498 A JP 2023537498A JP 2023537498 A JP2023537498 A JP 2023537498A JP 2023554674 A5 JP2023554674 A5 JP 2023554674A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063129480P | 2020-12-22 | 2020-12-22 | |
| US63/129,480 | 2020-12-22 | ||
| US202163170196P | 2021-04-02 | 2021-04-02 | |
| US63/170,196 | 2021-04-02 | ||
| PCT/US2021/073057 WO2022140774A1 (en) | 2020-12-22 | 2021-12-21 | Peptide markers to track genetically engineered cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023554674A JP2023554674A (ja) | 2023-12-28 |
| JPWO2022140774A5 JPWO2022140774A5 (https=) | 2024-12-20 |
| JP2023554674A5 true JP2023554674A5 (https=) | 2024-12-20 |
Family
ID=80218522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537498A Pending JP2023554674A (ja) | 2020-12-22 | 2021-12-21 | 遺伝子改変細胞追跡用ペプチドマーカー |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220195006A1 (https=) |
| EP (1) | EP4267606A1 (https=) |
| JP (1) | JP2023554674A (https=) |
| KR (1) | KR20230124983A (https=) |
| AU (1) | AU2021410077A1 (https=) |
| CA (1) | CA3202874A1 (https=) |
| IL (1) | IL303809A (https=) |
| MX (1) | MX2023007445A (https=) |
| TW (1) | TW202241937A (https=) |
| WO (1) | WO2022140774A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4192941A1 (en) | 2020-08-07 | 2023-06-14 | Neogene Therapeutics B.V. | Methods to enrich genetically engineered t cells |
| EP4635976A1 (en) * | 2024-04-19 | 2025-10-22 | Medigene Immunotherapies GmbH | Constant uni-tabs |
| WO2025219541A1 (en) * | 2024-04-19 | 2025-10-23 | Medigene Immunotherapies Gmbh | Constant uni-tabs |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1878744A1 (en) * | 2006-07-13 | 2008-01-16 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them |
| WO2016079333A1 (en) * | 2014-11-20 | 2016-05-26 | Umc Utrecht Holding B.V. | Use of antibodies for enrichment of engineered t cells with exogenous immune receptors and antibodies for use in depletion of engineered t cells |
| CN110352068A (zh) * | 2016-12-02 | 2019-10-18 | 南加利福尼亚大学 | 合成的免疫受体及其使用方法 |
| RU2761377C2 (ru) | 2017-04-03 | 2021-12-07 | Ф. Хоффманн-Ля Рош Аг | Иммуноконъюгаты антитела к pd-1 с мутантом il-2 или с il-15 |
| AU2018345400B2 (en) * | 2017-10-05 | 2024-06-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for selectively expanding cells expressing a TCR with a murine constant region |
| EP3946382A1 (en) * | 2019-04-04 | 2022-02-09 | UMC Utrecht Holding B.V. | Modified immune receptor constructs |
-
2021
- 2021-12-21 US US17/557,514 patent/US20220195006A1/en active Pending
- 2021-12-21 CA CA3202874A patent/CA3202874A1/en active Pending
- 2021-12-21 EP EP21854791.7A patent/EP4267606A1/en active Pending
- 2021-12-21 JP JP2023537498A patent/JP2023554674A/ja active Pending
- 2021-12-21 TW TW110147984A patent/TW202241937A/zh unknown
- 2021-12-21 MX MX2023007445A patent/MX2023007445A/es unknown
- 2021-12-21 KR KR1020237024600A patent/KR20230124983A/ko active Pending
- 2021-12-21 WO PCT/US2021/073057 patent/WO2022140774A1/en not_active Ceased
- 2021-12-21 AU AU2021410077A patent/AU2021410077A1/en active Pending
- 2021-12-21 IL IL303809A patent/IL303809A/en unknown